Tag Archives: Haemophilia

MoH approves ‘Elocta’ for treatment of haemophilia A

STOCKHOLM, Nov 22, (Business Wire): Swedish Orphan Biovitrum AB (publ) (STO:SOBI) (Sobi) today announced that the Ministry of Health in Kuwait has approved Elocta. (efmoroctocog alfa), a recombinant human factor VIII Fc-fusion protein with an extended half-life, for the treatment of haemophilia A. Elocta is the first recombinant factor VIII …

Read More »
Translate »